Skip to main content
Medical information Clinical review pending

Genetic Testing

HLA B15 B15 Test

The HLA B15 B15 Test identifies a specific genetic marker linked to certain disease risks. This test helps understand individual susceptibility and informs medical decisions. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
4 mL (3 mL minimum) whole blood in 1 Lavender Top (EDTA) tube OR 6 mL (3 mL minimum) whole blood in 1 Yellow Top (ACD) tube.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required before the test.
Test priceKSh 12,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the HLA B15 B15 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with a family history of diseases associated with HLA B15 B15.
  • ✓Patients presenting symptoms suggestive of immunological disorders.
  • ✓Individuals considering medications known to have associations with HLA B15 B15.
  • ✓Risk assessment for specific drug reactions.
02

In plain language

What this test helps you understand

Identifies the presence of the HLA B15 B15 antigen, which is associated with increased risk for certain diseases, particularly severe cutaneous adverse reactions (SCARs) to specific medications in certain populations. Results can inform risk assessment and guide medication choices.
The HLA B15 B15 Test is a diagnostic procedure used to evaluate specific genetic markers associated with various health conditions. Understanding these markers can help healthcare providers assess an individual's susceptibility to certain diseases and guide appropriate medical advice and treatment strategies. This test is particularly relevant for individuals with specific risk factors or symptoms.

This test specifically measures the presence of the HLA B15 B15 antigen. Identifying this antigen can provide insights into predispositions to certain medical conditions, aiding in further diagnostic and therapeutic planning.

Individuals who might benefit from this test include those with a family history of diseases associated with HLA B15 B15, patients presenting symptoms related to immunological disorders, or individuals whose treatment may be influenced by genetic factors.

Key benefits of the HLA B15 B15 Test include identifying genetic predispositions to certain diseases, supporting informed decision-making about treatment options, and enhancing personal health understanding.

Results indicate the presence or absence of the HLA B15 B15 antigen. A positive result may suggest an increased risk for certain conditions, while a negative result may indicate lower susceptibility. It is essential to discuss your results with a healthcare provider for accurate interpretation and guidance.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required before the test.
Sample4 mL (3 mL minimum) whole blood in 1 Lavender Top (EDTA) tube OR 6 mL (3 mL minimum) whole blood in 1 Yellow Top (ACD) tube.
MethodologyMolecular genetic testing (e.g., PCR-based methods) is typically used to detect the specific HLA B15 B15 allele.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test identifies the presence of the HLA B15 B15 antigen but does not guarantee the development of associated diseases. It is one factor among many influencing health outcomes. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects the presence of a specific genetic marker called the HLA B15 B15 antigen, which is linked to an increased risk for certain health conditions, particularly reactions to some medications.
Individuals with a family history of related conditions, those experiencing specific symptoms, or those prescribed medications known to interact with this genetic marker may benefit from this test. Consult your doctor.
A blood sample is required for this test. The laboratory requires either a Lavender Top (EDTA) or Yellow Top (ACD) tube.
Turnaround time varies. Please confirm the current estimated turnaround time with the laboratory before booking your test.
Results will indicate if the HLA B15 B15 antigen is present. A positive result may indicate a higher risk for certain conditions or reactions. Discuss the results with your healthcare provider for interpretation.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp